{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:05:55Z","timestamp":1773767155659,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10067-014-2520-7","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T04:51:23Z","timestamp":1392180683000},"page":"549-553","source":"Crossref","is-referenced-by-count":48,"title":["The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort"],"prefix":"10.1007","volume":"33","author":[{"given":"Hadar","family":"Duskin-Bitan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eytan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elad","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzippy","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Garty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"2520_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","volume":"364","author":"T Neogi","year":"2011","unstructured":"Neogi T (2011) Gout. N Engl J Med 364:443\u2013452","journal-title":"N Engl J Med"},{"key":"2520_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","volume":"82","author":"EW Campion","year":"1987","unstructured":"Campion EW, Glynn RJ, DeLabry LO (1987) Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 82:421\u2013426","journal-title":"Am J Med"},{"key":"2520_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(67)90004-6","volume":"42","author":"AP Hall","year":"1967","unstructured":"Hall AP, Barry PE, Dawber TR, McNamara PM (1967) Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 42:27\u201337","journal-title":"Am J Med"},{"key":"2520_CR4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0889-857X(21)00887-5","volume":"6","author":"R Roubenoff","year":"1990","unstructured":"Roubenoff R (1990) Gout and hyperuricemia. Rheum Dis Clin North Am 6:539\u2013550","journal-title":"Rheum. Dis. Clin. North Am"},{"key":"2520_CR5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2011-201254","volume":"72","author":"G Trifir\u00f2","year":"2013","unstructured":"Trifir\u00f2 G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M et al (2013) Epidemiology of gout and hyperuricaemia in Italy during the years 2005\u20132009: a nationwide population-based study. Ann Rheum Dis 72:694\u2013700","journal-title":"Ann Rheum Dis"},{"key":"2520_CR6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med 125:679\u2013687","journal-title":"Am J Med"},{"key":"2520_CR7","first-page":"2403","volume":"29","author":"E Arromdee","year":"2002","unstructured":"Arromdee E (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403\u20132406","journal-title":"J Rheumatol"},{"key":"2520_CR8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ncprheum0556","volume":"3","author":"E Roddy","year":"2007","unstructured":"Roddy E (2007) The changing epidemiology of gout. Nat Clin Pract Rheumatol 3:443\u2013449","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2520_CR9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005. Ann Rheum Dis 67:960\u2013966","journal-title":"Ann Rheum Dis"},{"key":"2520_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/ard.56.1.22","volume":"56","author":"P Klemp","year":"1997","unstructured":"Klemp P, Stansfield SA, Castle B, Robertson MC (1997) Gout is on the increase in New Zealand. Ann Rheum Dis 56:22\u201326","journal-title":"Ann Rheum Dis"},{"key":"2520_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"T Mikuls","year":"2005","unstructured":"Mikuls T, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990\u20131999. Ann Rheum Dis 64:267\u2013272","journal-title":"Ann Rheum Dis"},{"key":"2520_CR12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/bmj.331.7517.623","volume":"331","author":"A Guti\u00e9rrez-Mac\u00edas","year":"2005","unstructured":"Guti\u00e9rrez-Mac\u00edas A, Lizarralde-Palacios E, Mart\u00ednez-Odriozola P, Miguel-De la Villa F (2005) Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 331:623\u2013624","journal-title":"BMJ"},{"key":"2520_CR13","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1055\/s-2001-18563","volume":"126","author":"B Hammer","year":"2001","unstructured":"Hammer B, Link A, Wagner A, B\u00f6hm M (2001) Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome. Dtsch Med Wochenschr 126:1331\u20131334","journal-title":"Dtsch Med Wochenschr"},{"key":"2520_CR14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 64:1447\u20131461","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2520_CR15","first-page":"3596","volume-title":"Harrison principles of internal medicine","author":"A Kratz","year":"2012","unstructured":"Kratz A, Pesce MA, Fink DJ (2012) Laboratory values of clinical importance. In: Fauci AS, Braunwald E, Kasper D et al (eds) Harrison principles of internal medicine, 18th edn. McGraw Hill, New York, USA, p 3596","edition":"18"},{"key":"2520_CR16","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/ndt\/gfp192","volume":"24","author":"SI Min","year":"2009","unstructured":"Min SI, Yun IJ, Kang JM, Park YJ, Min SK, Ahn C et al (2009) Moderate to severe early onset hyperuricemia: a prognostic marker of long term kidney transplant outcome. Nephrol Dial Transplant 24:2584\u20132590","journal-title":"Nephrol Dial Transplant"},{"key":"2520_CR17","unstructured":"Schumacher HR, Chen LX (2012) Gout and other crystal-associated arthropathies. In: Fauci AS, Braunwald E, Kasper D et al (eds) Harrison principles of internal medicine, 18th edn. McGraw Hill, New York, USA, pp 2012\u20132837"},{"key":"2520_CR18","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/archinte.1986.00360230161022","volume":"146","author":"E Lally","year":"1986","unstructured":"Lally E, Ho G Jr, Kaplan SR (1986) The clinical spectrum of gouty arthritis in women. Arch Intern Med 146:2221\u20132225","journal-title":"Arch Intern Med"},{"key":"2520_CR19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archinte.1991.00400040074016","volume":"151","author":"J Puig","year":"1991","unstructured":"Puig J, Mich\u00e1n AD, Jim\u00e9nez ML, P\u00e9rez de Ayala C, Mateos FA, Capit\u00e1n CF et al (1991) Female gout. Clinical spectrum and uric acid metabolism. Arch Intern Med 151:726\u2013732","journal-title":"Arch Intern Med"},{"key":"2520_CR20","first-page":"1859","volume":"35","author":"Z Miao","year":"2008","unstructured":"Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859\u20131864","journal-title":"J Rheumatol"},{"key":"2520_CR21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archinte.1987.00370040027005","volume":"47","author":"HG Langford","year":"1987","unstructured":"Langford HG, Blaufox MD, Borhani NO, Curb JD, Molteni A, Schneider KA et al (1987) Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 47:645\u2013649","journal-title":"Arch Intern Med"},{"key":"2520_CR22","doi-asserted-by":"crossref","unstructured":"Choi HK, Soriano LC, Zhang Y, Rodr\u00edguez LA (2012) Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 344:d8190:1\u20139","DOI":"10.1136\/bmj.d8190"},{"key":"2520_CR23","first-page":"1501","volume":"27","author":"KC Lin","year":"2000","unstructured":"Lin KC, Chou P (2000) The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 27:1501\u20131505","journal-title":"J Rheumatol"},{"key":"2520_CR24","first-page":"676","volume":"14","author":"E Cohen","year":"2012","unstructured":"Cohen E, Krause I, Fraser A, Goldberg E, Garty M (2012) Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. IMAJ 14:676\u2013680","journal-title":"IMAJ"},{"key":"2520_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ypmed.2004.06.004","volume":"40","author":"N Bilenko","year":"2005","unstructured":"Bilenko N, Fraser D, Vardi H, Shai I, Shahar DR (2005) Mediterranean diet and cardiovascular diseases in an Israeli population. Prev Med 40:299\u2013305","journal-title":"Prev Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2520-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2520-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T10:20:24Z","timestamp":1648290024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2520-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["2520"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2520-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}